Comparative effectiveness and safety of direct-acting oral anticoagulants (DOACS) for the reduction of recurrent venous thromboembolism in cancer patients
Mohammed Danjuma(Hamad Medical Corporation), Mubarak A. Bidmos(Qatar University), Mohamed Mohamedali(New York Public Library), Yahya Mahgboub(New York Public Library), Anand Kartha(Hamad General Hospital), Shaikha D. Al-Shokri(MetroHealth), Abdel‐Naser Elzouki(New York Public Library), Mohamad Nabil ElShafei(Hamad Medical Corporation), Ibrahim Y. Abubeker(Brown University), Sara Mohamed(Royal College of Surgeons in Ireland - Bahrain), Haajra Fatima(Hamad Medical Corporation), Mouhand Mohamed(Mayo Clinic)
Cited by 0
Related Papers
Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity
|Cytokine|2015|505
Conductance catheter measurements of left ventricular volume in the intact dog: parallel conductance is independent of left ventricular size
|Cardiovascular Research|1994|47
Prevalence of Venous Thromboembolism in Critically Ill COVID-19 Patients: Systematic Review and Meta-Analysis
|Frontiers in Cardiovascular Medicine|2021|41